Navigation Links
Clarient Acquires Applied Genomics, Inc.
Date:12/21/2009

urce, having created a state-of-the-art commercial cancer laboratory, which provides the most advanced oncology testing and diagnostic services available. Resulting diagnostic reports and analyses are made available to customers through Clarient's Internet-based portal, PATHSiTE(TM). Clarient is also developing and marketing new, proprietary "companion" diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia/lymphoma. www.clarientinc.com

Forward Looking Statements

Certain statements herein regarding Clarient, Inc. contain forward-looking statements that involve risks and uncertainty. Future events and Clarient's actual results could differ materially from the results reflected in these forward-looking statements. Factors that might cause such a difference include, but are not limited to: Clarient's ability to continue to develop and expand its diagnostic services business, uncertainties inherent in Clarient's product development programs, Clarient's ability to expand and maintain a successful sales and marketing organization, Clarient's ability to obtain additional financing on acceptable terms or at all, uncertainty of success in identifying and developing new diagnostic tests or novel markers, Clarient's ability to fund development of new diagnostic tests and novel markers and the amount of resources Clarient determines to apply to novel marker development and commercialization, failure to obtain FDA clearance or approval for particular applications, Clarient's ability to compete with other technologies and with emerging competitors in novel cancer diagnostics and dependence on third parties for collaboration in developing new tests, Clarient's ability to successfully inte
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
2. Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer
3. Clarient Announces CFO Transition Plan
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
6. U.S. Preventive Medicine Acquires Specialty Disease Management
7. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Calif. , May 28, 2015  IRIDEX Corporation (NASDAQ: ... Chief Financial Officer James H. Mackaness is scheduled ... 3, 2015, at 9:00 am PT in Los ... the presentation may be accessed on the Event Calendar of ...  A replay of the webcast will be available shortly after ...
(Date:5/28/2015)... 2015 Research and ... of the  "North America Ultrasound Devices Market ... 2019)"  report to their offering.  ... a type of imaging. It uses high-frequency ... and structures inside the body. Health care ...
(Date:5/28/2015)... , May 28, 2015   Mast ... biopharmaceutical company leveraging its molecular adhesion and sealant ... sickle cell disease, heart failure, and arterial disease, ... from the Company,s Board of Directors. Mr. Lief ... of interest given his role as President and ...
Breaking Medicine Technology:North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4
... April 8, 2011 ImageXpres Corporation (Pink Sheets: ... financial results and annual report that highlighted the key ... 31, 2010. Overall financial results for 2010 demonstrated significant ... and net income of $109,033 for all of 2010, ...
... 8, 2011 Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ... of drugs for the treatment of human viral diseases, today ... 18,310,000 shares of its common stock at a public offering ... being sold by Idenix. The offering is expected to close ...
Cached Medicine Technology:ImageXpres Posts OTC Markets 2010 Annual Report 2ImageXpres Posts OTC Markets 2010 Annual Report 3Idenix Pharmaceuticals Prices Public Offering of Common Stock 2
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe is ... Joint Fluid Therapy (JFT) at their clinics in Orange ... injectable treatment that assists in diminishing pain for patients ... Dr. Stanley Katz and Dr. Neil Katz of Healthpointe. ... sodium hyaluronate (also known as hyaluronic acid) a natural ...
(Date:5/29/2015)... Clarkston, Metamora, Michigan (PRWEB) May 29, 2015 ... vulvar region and can cause significant physical, sexual, and ... major life altering disorder of Vulvodynia. The actual diagnosis ... Women’s Excellence in Endometriosis, they realize that this problem ... patient is experiencing any of these symptoms, they need ...
(Date:5/29/2015)... May 29, 2015 The popular all-natural ... their rewards based L-Style Select Program that gives bonuses ... is limited to only 100 members per year, lucky ... one on one with fitness experts at Nuretix Research, ... to them provided that they attain and maintain their ...
(Date:5/29/2015)... Health DataPalooza is a national conference that brings ... the most effective and innovative ways to use open ... by the Health Data Consortium, which is a collaboration ... develop the use of open healthcare data. Within ... in on how to actually put the ideas into ...
(Date:5/29/2015)... 29, 2015 External Counterpulsation, also known as ... treatment for patients. The Heart Fit Clinic is the first ... a raving review from patients who are now completing treatment. ... underwent 35 treatments of ECP treatment and received great results. ... Not only does the clinic perform this non-surgical treatment for ...
Breaking Medicine News(10 mins):Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:Liporidex, a Sports Nutrition Supplement Brand, Is Searching For Members For Their Exclusive L-Style Select Program Which Rewards Members For Their Achievements 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2
... ... supplements, announces the release of their new Lycopene Omega-3 Super Formula. , ... (PRWEB) February 1, 2010 -- ... their new Lycopene Omega-3 Super Formula ., , ,The new formula further strengthens ...
... , AURORA, Colo. , Feb. 1 ... (CID4) launches this month with a statewide "Call for Proposals" from ... active management.  The announcement is made by Kevin M. Smith ... 20,000 good-paying jobs in Colorado , the life sciences industry ...
... Little difference in survival found 10 years after therapies, ... Long-term survival rates are similar for leukemia patients who,ve ... marrow transplants, a new European study says. , The ... PBSC or bone marrow transplants from a matched sibling ...
... Third Season Features New Dating ... (PRWEB) January 29, 2010 ... game show in which three single women or men will prepare a dish to be selected ... , , , ,Cooking for Bachelors, dubbed by Channel12News and the Brooklyn Paper as the show ...
... ... , ... 2010 -- Canadian NGO, The Nancy Nielsen Charitable Foundation, and its Kenyan agent, Cherish ... a demonstration run/walk to protest FGM in the Transmara. The 4 kilometer event will ...
... ... Nutrition™ ( http://www.kardeanutrition.com ) is pleased to announce that it has teamed with ... Cardiologist®, ( http://www.thecookingcardiologist.com/ ) to develop an integrated nutritional approach that advances cardiovascular ... ...
Cached Medicine News:Health News:Purity Products Releases Their Next Generation Lycopene Omega-3 Super Formula 2Health News:The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide 'Call for Proposals' From Life Science Technologies in Need of Funding and Active Management 2Health News:Stem Cell, Bone Marrow Transplants Both Benefit Leukemia Patients 2Health News:Cooking For Bachelors Seeks Singles Cooking For Love 2Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 2Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 3Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 4Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 5Health News:Kardea Nutrition & The Cooking Cardiologist Join to Create Gourmet System for Heart Health 2Health News:Kardea Nutrition & The Cooking Cardiologist Join to Create Gourmet System for Heart Health 3
XL STABI Hydrophilic Acrylic Lens....
TRIPODE Hydrophilic Acrylic Lens....
Biocryl™ Acrylic Foldable Lens....
The STAAR ELASTIMIDE lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
Medicine Products: